Program Information denotes Call for Presentation Selection
Wednesday, June 10 (continued)
Alliance for the Prudent Use of Antibiotics (APUA) Leadership
Award for their work on antibiotic use improvement and infection
1:30 PM - 2:30 PM
prevention and control in the Netherlands.
Mock Deposition - Rising Tide of HAI Lawsuits
1:30 PM - 2:30 PM
Barry D. Trebach, JD, Partner
The Unique Challenges of Pediatric
Bonner Kiernan Trebach & Crociata, LLP, Washington, DC
Populations
Tammy Lundstrom, MD, JD
Sharon “Brie” Alexander, MPH, BSN, RN, CIC
Chief Medical Officer Providence and Providence Park Hospitals
Infection Control Professional
Southfield, MI
Children’s Hospital of Philadelphia, Philadelphia, PA
Associate Professor of Medicine, Wayne State University and
Adjunct Professor of Law, Wayne State University
Michael Cloughessy, BSEH, REHS, CIC
Infection Control Practitioner
Thomas R. Talbot, MD, MPH
Cincinnati Children’s Hospital, Cincinnati, OH
Assistant Professor of Medicine and
Chief Hospital Epidemiologist
The pediatric population provides unique challenges. The
Vanderbilt University School of Medicine, Nashville, TN
presenters will discuss specific diseases, isolation precautions,
environmental issues and the relation of these to pediatric disaster
This session will present the litigation process in the form of a
planning.
mock HAI trial. Gathering facts via the deposition process, the
role of the defense, offense and subject will be demonstrated.
1:30 PM - 2:30 PM
1:30 PM - 2:30 PM
The Use of Vaporized Hydrogen Peroxide
Room Decontamination in the Management
Multi-Drug Resistant Organisms: It’s Not
of an Outbreak of Multidrug-Resistant
Just About MRSA
Acinetobacter baumannii
Titus Daniels, MD, MPH
Amy Ray, MD
Assistant Professor of Medicine – VUSM
Medical Director, System Infection Control Committee
Associate Hospital Epidemiologist – Vanderbilt Medical Center,
Department of Medicine, Division of ID & HIV Medicine
Nashville, TN
Case Western Reserve University, Cleveland, OH
An alarming trend is emerging among multi-drug resistant gram-
The presenter will discuss the technology of vaporized hydrogen
negative (MDRGN) bacteria. These bacteria present a public
peroxide decontamination and its potential uses within healthcare
health crisis that demands urgent attention and intervention.
facilities. Dr. Ray will discuss the role of the environment
The presenter will address the epidemiology, risk factors, and
in transmission of healthcare-associated pathogens such as
strategies to prevent the spread of MDRGN Bacteria.
Acinetobacter baumannii. An outbreak will be described which
Session is sponsored by an unrestricted education
occurred in a long-term acute care hospital setting.
grant from BD. The speaker is not sponsored.
1:30 PM - 2:30 PM
1:30 PM - 2:30 PM
What Every IP Needs to Know When Doing
1/6
The Continuing Story:
Rounds in the Sterile Processing Department
Eliminating MRSA in the Netherlands
Rose Seavey, RN, BS, MBA, CNOR, CRCST, CSPDT
Gertie G. M. van Knippenberg-Gordebeke
President/CEO
Consultant Infection Prevention
Seavey Healthcare Consulting, Inc., Arvada, CO
KNIP Consultancy Infection Prevention
Venlo-Boekend, Netherlands
Sterile processing must ensure that every instrument meets
decontamination, sterilization and sterile storage requirements.
The Netherlands has an internationally recognized program for
The presenter will give the infection preventionist tools to help
elimination of MRSA the so called Search and Destroy Policy.
ensure their sterile processing department is in compliance with
The MRSA rate in June 2007 was 1.4%. In 2008 the Dutch
best evidence-based practices. The latest in flash sterilization and
Working Party on Antibiotic Policy (SWAB) and the Dutch
documentation and controls on loaner instrumentation will be
Working Party on Infection Prevention (WIP) received the
discussed.
18 Visit
www.apic.org for updates
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32